These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 888377)

  • 21. Fibrinogen and plasminogen activator inhibitor-1 levels in hypertension and coronary heart disease. Potential effects of beta-blockade.
    Teger-Nilsson AC; Larsson PT; Hjemdahl P; Olsson G
    Circulation; 1991 Dec; 84(6 Suppl):VI72-7. PubMed ID: 1683612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Does chronic therapy of hypertension with acebutolol or hydrochlorothiazide effect coronary risk factors?].
    Witkowska M; Kübler G; Kopel E; Karolko B
    Kardiol Pol; 1991; 34(3):143-50. PubMed ID: 2046225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Changes in levels of triglycerides, cholesterol, noradrenaline and lactates in the blood of patients with severe coronary insufficiency after long-term physical exertion of low intensity].
    Ziółkowski L; Wójcik-Ziółkowska E; Kozłowski S
    Przegl Lek; 1986; 43(8):552-8. PubMed ID: 3809562
    [No Abstract]   [Full Text] [Related]  

  • 24. [Blood coagulation and lipid metabolism in patients with coronary arteriosclerosis].
    Batrak AA
    Vrach Delo; 1976 Jun; (6):17-9. PubMed ID: 969450
    [No Abstract]   [Full Text] [Related]  

  • 25. [Value of determining plasma renin activity in patients with essential arterial hypertension and coronary disease].
    Popescu P; Anghel S; Moldovan T; Albu A; Barău L; Ciocoiu C
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984; 36(5):417-24. PubMed ID: 6151229
    [No Abstract]   [Full Text] [Related]  

  • 26. [Thrombin activity in the blood of patients with coronary insufficiency and hypertension].
    Panchenko VM; Pastorova VE
    Ter Arkh; 1968 Feb; 40(2):64-7. PubMed ID: 5675775
    [No Abstract]   [Full Text] [Related]  

  • 27. [An eicosapentaenoic acid-rich diet in relation to a reducing diet and physical training].
    Herrmann W; Biermann J; Lindhofer HG; Hanf S; Reuter W
    Z Gesamte Inn Med; 1987 Apr; 42(8):212-5. PubMed ID: 2820157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of physical exertion on the changes in arterial blood pressure, heart rate and electrocardiogram in orthostatic position].
    Vilkov VG; Shamarin VM; Shal'nova SA; Dmitrieva VS
    Kosm Biol Aviakosm Med; 1988; 22(4):43-7. PubMed ID: 3226093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coronary heart disease in the young.
    Maddox K
    Cardiovasc Clin; 1971; 2(3):79-86. PubMed ID: 4950429
    [No Abstract]   [Full Text] [Related]  

  • 30. [The laser therapy of patients with hypertension in combination with coronary insufficiency].
    Kniazeva TA; Badtieva VA; Zubkova SM
    Vopr Kurortol Fizioter Lech Fiz Kult; 1996; (2):3-5. PubMed ID: 8928439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of aspirin on plasma fibrinolytic activity in patients of coronary heart disease.
    Jain A; Mehrotra TN; Goel VK; Mehrotra ML; Raka MS
    J Assoc Physicians India; 1982 Jul; 30(7):441-3. PubMed ID: 7169468
    [No Abstract]   [Full Text] [Related]  

  • 32. [Thromboelastographic study of coagulation and fibrinolysis in coronary diseases].
    Fiori W; Civai O; Pizzoferrato A
    Atti Accad Fisiocrit Siena Med Fis; 1966; 15(1):139-82. PubMed ID: 6001423
    [No Abstract]   [Full Text] [Related]  

  • 33. [Diagnostic importance of the atherothrombophilia index in cardiologic diseases].
    Zolotarev AE; Zakatova LV
    Vrach Delo; 1980 Jul; (7):29-30. PubMed ID: 7415086
    [No Abstract]   [Full Text] [Related]  

  • 34. [Editorial: Physical activity in the prevention of coronary disease].
    Koztowski S
    Kardiol Pol; 1973; 16(4):261-7. PubMed ID: 4756960
    [No Abstract]   [Full Text] [Related]  

  • 35. [Status of fibrinolysis and the reactivity of thrombocytes in patients with hypertension and coronary arteriosclerosis].
    Kartsev AN
    Klin Med (Mosk); 1986 Jul; 64(7):103-7. PubMed ID: 3762023
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hypofibrinolysis in coronary artery disease and predisposing conditions].
    Torrado del Puerto MC; García Frade LJ; García Avello A
    Rev Clin Esp; 1992 Jun; 191(1):1-2. PubMed ID: 1631353
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical investigations on long-term activation of fibrinolysis by anabolic steroids.
    Bielawiec M; Bodzenta A; Lukjan H; Kiersnowska-Rogowska B; Kłoczko J; Myśliwiec M; Dabrowski S; Tymiński W; Czestochowska E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):223-9. PubMed ID: 2427405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Blood fibrinolytic system in the principal cardiovascular diseases].
    Gritsiuk AI
    Kardiologiia; 1971 Oct; 11(10):51-8. PubMed ID: 5138045
    [No Abstract]   [Full Text] [Related]  

  • 39. [Physical training of patients with coronary sclerosis].
    Clausen JP; Larsen OA; Trap-Jensen J
    Nord Med; 1969 Aug; 82(33):1005-11. PubMed ID: 5808589
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of risk factors on the tolerance to physical exertion in chronic ischemic heart disease].
    Taktuk EE
    Vrach Delo; 1981 Apr; (4):71-4. PubMed ID: 7196644
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.